Sperm DNA Fragmentation

Understanding Sperm DNA Fragmentation (SDF) and Karyotyping

Understanding Sperm DNA Fragmentation (SDF) and Karyotyping in Recurrent Pregnancy Loss and Adverse Pregnancy Outcomes

Sperm DNA Fragmentation (SDF)

This article explains the importance of sperm DNA fragmentation (SDF) testing and karyotyping in couples affected by RPL, infertility, and genetic conditions in pregnancy. It also explores the impact of lifestyle and age-related male factors on reproductive outcomes and summarises current UK and European guidance.

Recurrent pregnancy loss (RPL), poor pregnancy outcomes, and fetal genetic abnormalities are commonly investigated through maternal factors. However, there is now increasing recognition that male factors, particularly sperm DNA integrity and paternal chromosomal abnormalities, may play a significant role.
Male Factor Contribution to Pregnancy Loss and Subfertility

Although historically under-investigated, male factors are now believed to contribute to:
– Up to 40–50% of couples experiencing infertility
– 20–40% of cases of unexplained recurrent pregnancy loss

A standard semen analysis only evaluates sperm count, motility, and morphology. However, it does not assess DNA integrity, which is essential for normal fertilisation, embryo development, and fetal genetic stability.

What Is Sperm DNA Fragmentation (SDF)?

Sperm DNA fragmentation (SDF) refers to structural damage in the DNA carried by sperm. High levels of fragmentation have been associated with:

– Increased risk of recurrent miscarriage
– Reduced embryo quality
– Failed implantation after IVF or ICSI
– Possible increased risk of fetal genetic abnormalities

Causes of Increased Sperm DNA Fragmentation

SDF can be caused by several factors:
– Advanced paternal age
– Smoking
– Obesity
– Excessive alcohol use
– Varicoceles
– Exposure to heat or toxins
– Genital tract infections
– Oxidative stress

What Does SDF Testing Involve?

Sperm DNA fragmentation can be assessed using several laboratory techniques, including:
– TUNEL assay
– SCSA (Sperm Chromatin Structure Assay)
– COMET assay
– SCD (Sperm Chromatin Dispersion)

These tests provide a DNA fragmentation index (DFI) or equivalent score. A high DFI is associated with an increased risk of pregnancy loss, particularly when no female cause is found.

The Importance of Karyotyping

Karyotype testing or chromosome testing is a laboratory test that analyses the number and structure of chromosomes. Structural rearrangements such as balanced translocations, inversions, or sex chromosome abnormalities in either partner can significantly increase the risk of miscarriage or fetal anomalies. Reporting time is typically around 3 weeks.

In couples with recurrent miscarriage, chromosomal abnormalities are found in around 2–6% of cases, more commonly in those with three or more losses.

Karyotyping is especially recommended when:
– There is a history of multiple pregnancy losses
– There has been a pregnancy affected by a chromosomal anomaly
– Embryo development has repeatedly failed or arrested
– There is a personal or family history of genetic conditions

Paternal Age

Advanced paternal age (>40 years) has been linked with:
– Increased sperm DNA fragmentation
– Higher risk of de novo genetic mutations
– Increased miscarriage rates
– Higher risk of neurodevelopmental conditions such as autism and schizophrenia

Lifestyle and Environmental Factors

Lifestyle factors can affect sperm quality and DNA integrity. These include:
Smoking – Increases DNA damage and oxidative stress
Obesity – Disrupts hormone balance and increases ROS
Alcohol – Affects sperm structure and motility
Poor Diet – Reduces antioxidant defences
Stress – Disrupts hormonal regulation
Heat/chemical exposure – Can damage DNA

The Role of Antioxidants in Sperm DNA Fragmentation (SDF)

As oxidative stress is a major contributor to DNA fragmentation, antioxidants are frequently used as a treatment strategy. Common supplements studied include:
– Vitamin C and E
– Zinc and selenium
– L-carnitine
– Coenzyme Q10
– N-acetylcysteine

Cochrane Review (2019) suggests antioxidants may modestly improve live birth and clinical pregnancy rates in subfertile men.

Current Clinical GuidanceRoyal College of Obstetricians and Gynaecologists (RCOG)
Green-top Guideline No. 17: Recurrent Miscarriage (2023 update)
– Recommends parental karyotyping when there are three or more miscarriages
– Notes emerging evidence for sperm DNA damage, not yet recommended for routine use
Full text: http://www.rcog.org.uk/media/mqpkob5r/gtg_17.pdf

European Society of Human Reproduction and Embryology (ESHRE)
– Advises parental karyotyping for unexplained RPL
– SDF testing may be considered where no female cause is found
Full text: https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Recurrent-Pregnancy-Loss.aspx

Summary Table

Investigation | Purpose | When to Offer
————-|———|—————
Sperm DNA Fragmentation Test: Evaluates hidden DNA damage in sperm. Consider if Recurrent miscarriage, poor embryo quality, IVF failure
Karyotype: Detects structural chromosome anomalies. Consider if Recurrent loss, fetal anomalies, infertility
Lifestyle Review: Identifies modifiable risk factors: Consider if All male partners in fertility workup
Antioxidants: May reduce oxidative sperm damage. Consider if High DNA fragmentation, poor semen parameters

Conclusion

Male factors are often under-recognised contributors to reproductive failure and genetic conditions. Sperm DNA fragmentation and chromosomal abnormalities may play a role in up to 40% of RPL cases and are increasingly considered in modern fertility evaluation.

At Innermost Healthcare, we offer:
– Parental karyotyping
– Sperm DNA fragmentation (SDF) testing (by arrangement)
– Personalised male fertility assessments
– Support with lifestyle optimisation and antioxidant supplementation

For more information, visit: https://innermosthealthcare.com

author avatar
Bryan Beattie Lead Consultant in Fetal Medicine
Dr Robert Bryan Beattie MB BCh BAO MD FRCOG Dr Beattie qualified in 1983 from Queen’s University Belfast and is sub-specialty trained in Fetal and Maternal Medicine. He also holds the RCOG/RCR Joint Diploma in Obstetric Ultrasound. He was a founder member of the British Maternal and Fetal Medicine Society and is an internationally recognised pregnancy expert who is regularly called upon to speak at conferences and events. Dr Beattie is the founding Chairman and Trustee of the Innermost Academy, a registered charity dedicated to improving education in pregnancy care.
Innermost Healthcare
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.